Form 13F-HR ATX Financial Planning, For: Sep 30
http://archive.fast-edgar.com/20261014/AQ2A922MC222J2W2222622E2P2R6Z2223282
Filed on: October 14, 2026
Form 8-K Evolution Metals & Techn For: Oct 14
false
0001866226
0001866226
2026-10-14
2026-10-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the... (continue reading...)
Form 8-K PULSE BIOSCIENCES, INC. For: Oct 14
false
0001625101
0001625101
2026-10-14
2026-10-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 14, 2026
Pulse Biosciences, Inc.
(Exact Name of Registrant as Specified in Its... (continue reading...)
Form 13F-HR Oliver Luxxe Assets LLC For: Sep 30
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 424B5 IonQ, Inc.
Table of Contents
Filed Pursuant to Rule 424(b)(5) Registration No. 333-285279
The information in this prospectus supplement is not complete and may be changed. This prospectus supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.
Subject to completion
Preliminary prospectus supplement dated October 14, 2026
PROSPECTUS SUPPLEMENT
(To Prospectus... (continue reading...)
More SEC Filings
View Older Stories-
Form ABS-15G Hildene Opportunities For: Sep 01
-
Form 8-K Eagle Point Credit Co For: Oct 14
-
Form 6-K OBOOK HOLDINGS INC. For: Oct 14
-
Form 13F-HR StoryOne LLC For: Sep 30
-
Form 8-K Data443 Risk Mitigation, For: Oct 14
-
Form 8-K Vir Biotechnology, Inc. For: Oct 09
-
Form 13F-HR FULTON BANK, N.A. For: Sep 30
-
Form 6-K CORPORACION AMERICA AIRP For: Oct 14
-
Form 10-Q CytoDyn Inc. For: Aug 31
-
Form SC 14D9/A ACV Auctions Inc. Filed by: ACV Auctions Inc.
-
Form D/A McWilliams Capital Fund,
-
Form 6-K GLOBALFOUNDRIES Inc. For: Oct 14
-
Form 8-K Eagle Point Income Co For: Oct 14
-
Form SCHEDULE 13D Troops, Inc. /Cayman Filed by: Prime Ocean Holdings Ltd
-
Form 4 LESAKA TECHNOLOGIES INC For: Aug 03 Filed by: Mazanderani Ali
-
Form 8-K Datacentrex, Inc. For: Oct 14
-
Form 8-K Coya Therapeutics, Inc. For: Oct 14
-
Form 6-K Biodexa Pharmaceuticals For: Oct 14
-
Form 3 M Evo Global Acquisition For: Oct 06 Filed by: Majlinder Jan Richard
-
Form 6-K BUUU Group Ltd For: Oct 14
-
Form 6-K Nuran Wireless Inc. For: Oct 14
-
Form 4 EuroDry Ltd. For: Oct 13 Filed by: Pittas Aristeidis P
-
Form D Cahero Korva Holding
-
Form DEFM14A Bowhead Specialty Holdin
-
Form 13F-HR HELIOS CAPITAL MANAGEMEN For: Sep 30
-
Form 424B2 CITIGROUP INC
-
Form 13F-HR Physician Wealth Solutio For: Sep 30
-
Form D Gaingels Weave LLC
-
Form D Cahero Nytra Holding
-
Form SC TO-I/A Medtronic plc Filed by: Medtronic plc
-
Form DEFA14A FLEX LTD.
-
Form 8-K Valion Bio, Inc. For: Oct 14
-
Form 13F-HR TRAPHAGEN INVESTMENT For: Sep 30
-
Form D Gaingels Coverd LLC
-
Form 8-K FLEX LTD. For: Oct 09
-
Form 6-K NatWest Group plc For: Oct 14
-
Form 8-K MAXCYTE, INC. For: Oct 14
-
Form 13F-HR Southland Equity Partner For: Sep 30
-
Form 6-K MINISO Group Holding For: Oct 14
-
Form 10-Q Jingbo Technology, Inc. For: Aug 31
-
Form 425 Medtronic plc Filed by: Medtronic plc
-
Form SC TO-T/A ACV Auctions Inc. Filed by: COPART INC
-
Form 8-K Sabre Corp For: Oct 13
-
Form 6-K Delixy Holdings Ltd For: Oct 14
-
Form S-1/A ACTUATE THERAPEUTICS,
-
Form 8-K Profound Medical Corp. For: Oct 14
-
Form 144 CLOUDASTRUCTURE, INC. Filed by: Bentley Sheldon Richard
-
Form SCHEDULE 13D/A AIFU Inc. Filed by: ZHAO ILEANA
-
Form SCHEDULE 13D/A AIFU Inc. Filed by: Liu Yif
-
Form 8-K Fermi Inc. For: Oct 14
